IDEAYA Biosciences (NASDAQ:IDYA – Get Rating) had its price target hoisted by Guggenheim from $32.00 to $40.00 in a report published on Monday, The Fly reports. Several other research analysts have also recently issued reports on IDYA. Berenberg Bank started coverage on shares of IDEAYA Biosciences in a report on Thursday, March 23rd. They issued […]
IDEAYA Biosciences (NASDAQ:IDYA – Get Rating) had its target price hoisted by Wedbush from $30.00 to $35.00 in a research note published on Monday morning, The Fly reports. IDYA has been the subject of several other research reports. TheStreet cut shares of IDEAYA Biosciences from a c- rating to a d+ rating in a research […]
IDEAYA Biosciences (NASDAQ:IDYA – Get Rating) had its price objective boosted by research analysts at Guggenheim from $32.00 to $40.00 in a research report issued to clients and investors on Monday, The Fly reports. Guggenheim’s target price indicates a potential upside of 111.98% from the stock’s current price. Several other equities analysts have also issued […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating)’s stock price traded up 7.5% on Monday . The company traded as high as $14.89 and last traded at $14.84. 155,872 shares changed hands during trading, a decline of 57% from the average session volume of 362,710 shares. The stock had previously closed at $13.80. Analysts Set New […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) has been given an average rating of “Moderate Buy” by the eleven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month […]